Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital, CSIC, University of Seville, Seville, Spain.
Department of Biostatistics, Faculty of Medicine, University of Granada, Granada, Spain.
PLoS One. 2022 Jul 14;17(7):e0269875. doi: 10.1371/journal.pone.0269875. eCollection 2022.
The SARS-CoV-2 pandemic has overwhelmed hospital services due to the rapid transmission of the virus and its severity in a high percentage of cases. Having tools to predict which patients can be safely early discharged would help to improve this situation.
Patients confirmed as SARS-CoV-2 infection from four Spanish hospitals. Clinical, demographic, laboratory data and plasma samples were collected at admission. The patients were classified into mild and severe/critical groups according to 4-point ordinal categories based on oxygen therapy requirements. Logistic regression models were performed in mild patients with only clinical and routine laboratory parameters and adding plasma pro-inflammatory cytokine levels to predict both early discharge and worsening.
333 patients were included. At admission, 307 patients were classified as mild patients. Age, oxygen saturation, Lactate Dehydrogenase, D-dimers, neutrophil-lymphocyte ratio (NLR), and oral corticosteroids treatment were predictors of early discharge (area under curve (AUC), 0.786; sensitivity (SE) 68.5%; specificity (S), 74.5%; positive predictive value (PPV), 74.4%; and negative predictive value (NPV), 68.9%). When cytokines were included, lower interferon-γ-inducible protein 10 and higher Interleukin 1 beta levels were associated with early discharge (AUC, 0.819; SE, 91.7%; S, 56.6%; PPV, 69.3%; and NPV, 86.5%). The model to predict worsening included male sex, oxygen saturation, no corticosteroids treatment, C-reactive protein and Nod-like receptor as independent factors (AUC, 0.903; SE, 97.1%; S, 68.8%; PPV, 30.4%; and NPV, 99.4%). The model was slightly improved by including the determinations of interleukine-8, Macrophage inflammatory protein-1 beta and soluble IL-2Rα (CD25) (AUC, 0.952; SE, 97.1%; S, 98.1%; PPV, 82.7%; and NPV, 99.6%).
Clinical and routine laboratory data at admission strongly predict non-worsening during the first two weeks; therefore, these variables could help identify those patients who do not need a long hospitalization and improve hospital overcrowding. Determination of pro-inflammatory cytokines moderately improves these predictive capacities.
由于病毒的快速传播及其在很大比例病例中的严重性,SARS-CoV-2 大流行使医院服务不堪重负。拥有预测哪些患者可以安全提前出院的工具将有助于改善这种情况。
从西班牙的四家医院确诊为 SARS-CoV-2 感染的患者。入院时收集临床、人口统计学、实验室数据和血浆样本。根据基于氧气治疗需求的 4 点序数类别,将患者分为轻症和重症/危重症组。在轻症患者中仅使用临床和常规实验室参数以及添加血浆促炎细胞因子水平进行逻辑回归模型,以预测早期出院和病情恶化。
共纳入 333 例患者。入院时,307 例患者被归类为轻症患者。年龄、血氧饱和度、乳酸脱氢酶、D-二聚体、中性粒细胞与淋巴细胞比值(NLR)和口服皮质类固醇治疗是早期出院的预测因素(曲线下面积(AUC),0.786;敏感性(SE)为 68.5%;特异性(S)为 74.5%;阳性预测值(PPV)为 74.4%;阴性预测值(NPV)为 68.9%)。当纳入细胞因子时,较低的干扰素诱导蛋白 10 和较高的白细胞介素 1β水平与早期出院相关(AUC,0.819;SE,91.7%;S,56.6%;PPV,69.3%;NPV,86.5%)。预测恶化的模型包括男性、血氧饱和度、无皮质类固醇治疗、C 反应蛋白和核苷酸结合寡聚化结构域样受体作为独立因素(AUC,0.903;SE,97.1%;S,68.8%;PPV,30.4%;NPV,99.4%)。通过纳入白细胞介素 8、巨噬细胞炎症蛋白 1β和可溶性白细胞介素 2 受体α(CD25)的测定,该模型略有改善(AUC,0.952;SE,97.1%;S,98.1%;PPV,82.7%;NPV,99.6%)。
入院时的临床和常规实验室数据强烈预测前两周内无恶化;因此,这些变量可以帮助识别那些不需要长时间住院治疗的患者,并改善医院拥挤状况。促炎细胞因子的测定适度提高了这些预测能力。